We are pleased to announce that Discovery Immunology, our broad-scope Open Access journal for new discoveries in cellular and molecular immunology, is now indexed in Scopus. Scopus, a leading abstract and citation database by Elsevier, serves as a key indicator of a journal’s quality and impact within the academic community
This is a crucial step in our vision to becoming an invaluable resource for the global immunology community. We'd like to thank our editorial board, led by Professor Simon Milling, for working hard to bring you high-quality articles from leading researchers worldwide. We also thank authors, reviewers and readers for their incredible support.
Discovery Immunology hit a major milestone in April when it was indexed in PubMed Central, one of the largest and most widely used repositories for biomedical and life sciences articles. Hitting these indexing milestones will enable us to bring our content to the wider global immunology community. It also published its first ever Special Collection in April, on checkpoint molecules in cancer immunotherapy.
Discovery Immunology publishes high-quality original research, reviews and short reports describing novel mechanisms controlling the immune response. We offer a quick turnaround from our supportive editorial team and, when accepted, your article would appear in PubMed Central and Scopus very soon after publication. Explore the journal’s latest content and submit your own article.
We offer all BSI members a 20% discount on publication fees for Discovery Immunology. You may also be able to publish your paper using funds available through Read and Publish deals with organisations from our publisher, Oxford University Press.
When you publish in our official journals, the profits are reinvested back into the BSI membership and our immunology community through the BSI grants, support of Regional and Affinity Group activities, travel awards, the BSI Congress and much more.
You can share your papers online and keep up to date with news from our journals by following @CEIjournal, @IMTadvances and @discovimmunol on X.